Literature DB >> 26004930

What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?

Ian Davis1, Aimin Liu.   

Abstract

The kynurenine pathway has received increasing attention as its connection to inflammation, the immune system and neurological conditions has become more apparent. It is the primary route for tryptophan catabolism in the liver and the starting point for the synthesis of nicotinamide adenine dinucleotide in mammals. Dysregulation or overactivation of this pathway can lead to immune system activation and accumulation of potentially neurotoxic compounds. These aspects make the kynurenine pathway a promising target for therapeutic development to treat inflammation and disease with neurological aspects, especially in cancer patients undergoing chemotherapy.

Entities:  

Keywords:  excitotoxicity; inflammation; melatonin; quinolinic acid; serotonin

Mesh:

Substances:

Year:  2015        PMID: 26004930      PMCID: PMC4482796          DOI: 10.1586/14737175.2015.1049999

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  24 in total

1.  Human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveiling.

Authors:  Lu Huo; Fange Liu; Hiroaki Iwaki; Tingfeng Li; Yoshie Hasegawa; Aimin Liu
Journal:  Proteins       Date:  2014-11-21

2.  Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2014-12       Impact factor: 84.694

Review 3.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

4.  The power of two: arginine 51 and arginine 239* from a neighboring subunit are essential for catalysis in α-amino-β-carboxymuconate-epsilon-semialdehyde decarboxylase.

Authors:  Lu Huo; Ian Davis; Lirong Chen; Aimin Liu
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

5.  My life with tryptophan--never a dull moment.

Authors:  O Hayaishi
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

6.  Tryptophan catabolism: identification and characterization of a new degradative pathway.

Authors:  Keri L Colabroy; Tadhg P Begley
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

Review 7.  An expanding range of targets for kynurenine metabolites of tryptophan.

Authors:  Trevor W Stone; Nicholas Stoy; L Gail Darlington
Journal:  Trends Pharmacol Sci       Date:  2012-11-01       Impact factor: 14.819

Review 8.  The kynurenine pathway of tryptophan degradation as a drug target.

Authors:  Robert Schwarcz
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

Review 9.  Depressive disorders and immunity: 20 years of progress and discovery.

Authors:  Michael R Irwin; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2007-03-13       Impact factor: 7.217

10.  Crystallographic and spectroscopic snapshots reveal a dehydrogenase in action.

Authors:  Lu Huo; Ian Davis; Fange Liu; Babak Andi; Shingo Esaki; Hiroaki Iwaki; Yoshie Hasegawa; Allen M Orville; Aimin Liu
Journal:  Nat Commun       Date:  2015-01-07       Impact factor: 14.919

View more
  42 in total

1.  Reassignment of the human aldehyde dehydrogenase ALDH8A1 (ALDH12) to the kynurenine pathway in tryptophan catabolism.

Authors:  Ian Davis; Yu Yang; Daniel Wherritt; Aimin Liu
Journal:  J Biol Chem       Date:  2018-04-27       Impact factor: 5.157

2.  Quaternary structure of α-amino-β-carboxymuconate-ϵ-semialdehyde decarboxylase (ACMSD) controls its activity.

Authors:  Yu Yang; Ian Davis; Tsutomu Matsui; Ivan Rubalcava; Aimin Liu
Journal:  J Biol Chem       Date:  2019-06-12       Impact factor: 5.157

3.  Rickettsial pathogen uses arthropod tryptophan pathway metabolites to evade reactive oxygen species in tick cells.

Authors:  Mustapha Dahmani; John F Anderson; Hameeda Sultana; Girish Neelakanta
Journal:  Cell Microbiol       Date:  2020-07-27       Impact factor: 3.715

4.  A Pitcher-and-Catcher Mechanism Drives Endogenous Substrate Isomerization by a Dehydrogenase in Kynurenine Metabolism.

Authors:  Yu Yang; Ian Davis; Uyen Ha; Yifan Wang; Inchul Shin; Aimin Liu
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

5.  Metabolic pathways of lung inflammation revealed by high-resolution metabolomics (HRM) of H1N1 influenza virus infection in mice.

Authors:  Joshua D Chandler; Xin Hu; Eun-Ju Ko; Soojin Park; Young-Tae Lee; Michael Orr; Jolyn Fernandes; Karan Uppal; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-24       Impact factor: 3.619

6.  High phthalate exposure increased urinary concentrations of quinolinic acid, implicated in the pathogenesis of neurological disorders: Is this a potential missing link?

Authors:  Feiby L Nassan; Joshua A Gunn; Melissa M Hill; Brent A Coull; Russ Hauser
Journal:  Environ Res       Date:  2019-02-22       Impact factor: 6.498

7.  The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer's disease.

Authors:  Jill K Morris; Brian D Piccolo; Kartik Shankar; John P Thyfault; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-26       Impact factor: 4.310

8.  Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic.

Authors:  George Theodoropoulos; Katerina Albanis; Medhi Wangpaichitr
Journal:  J Curr Sci Technol       Date:  2021-01

Review 9.  The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.

Authors:  Tao Yang; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

10.  Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.

Authors:  Dan J M Nguyen; George Theodoropoulos; Ying-Ying Li; Chunjing Wu; Wei Sha; Lynn G Feun; Theodore J Lampidis; Niramol Savaraj; Medhi Wangpaichitr
Journal:  Mol Cancer Res       Date:  2019-10-18       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.